Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.97%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-14.20%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-24.34%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-16.54%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year24.21%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range47.00 - 91.05 Perf YTD2.77%
Dividend0.51 P/FCF- EPS past 5Y- ROI- 52W High-30.08% Beta-
Dividend %0.80% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low35.45% ATR3.74
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)37.55 Volatility6.85% 5.46%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.18 Prev Close64.30
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.44M Price63.66
Recom- SMA20-9.92% SMA50-14.64% SMA200-14.72% Volume6,390,100 Change-1.00%
Oct-08-15 09:08AM  IBB and XBIs Top 10 Large-Cap Stocks Underperform
Oct-07-15 01:07PM  BioMarin Pharmaceutical Takes a Nosedive Last Week
12:50PM  Wednesday links: addicted to liquidity
10:55AM  Illumina Fell 10.6% on a Biotech Sell-Off
08:03AM  3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical at Motley Fool
Oct-05-15 11:45AM  Biotechs - Boom, Bust, Now Buy at Forbes
Oct-02-15 04:07PM  XBIs Top Ten Small-Cap Stocks Perform on Par with Large-Caps
04:07PM  ALNY and XON Drag Down Mid-Cap Stocks Last Week
02:53PM  Breaking Down Biotech ETFs With Leverage
Oct-01-15 02:26PM  Biotech: buy the dip?
10:22AM  Biotech: Out of the Ashes at
09:10AM  BioMarin Falls 16.81% in Week Ended September 25
08:55AM  Biotech ETFs Looking Attractive After Sell-Off
07:50AM  China Whacks the Caixin/Markit Survey - Try the Shells in a White Wine, Sausage Cream Sauce
12:06AM  Alkermes and Incyte Outperform in Large-Cap Space
Sep-30-15 11:57PM  Has The Biotech Stock Bubble Popped? at Forbes
02:25PM  XBIs Moving Averages: The Massive Plummet Last Week
02:25PM  Biotech Stocks Hammered Badly Last Week after Clinton Comment
02:09PM  Biotech: Will Valuation End the Carnage? at
07:45AM  Lets Play Dress Up - Try the Risotto di Limone & Gamberi (Lemon Risotto w/Shrimp)
Sep-29-15 02:50PM  Price controls on biotech do not work: Pro
12:09PM  XBIs Top Ten Small-Caps Outperform IBBs Top Ten Small-Caps
Sep-28-15 05:06PM  Opko Health Falls 7.7% in Week Ended September 11 -7.19%
04:55PM  Biotech fund posts worst single-day drop in 4 years at MarketWatch
02:04PM  Step away from biotechs, let dust settle: Pro
01:33PM  Drug Pricing Fears Erase Biotech Stock Gains for the Year at TheStreet
01:03PM  Good-Bye Biotech Bull, Hello Pain at
12:16PM  Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
11:58AM  Gilead Sciences: 'The Machine Marches Forward' at
11:30AM  Biotech Moves Into A Bear Market And This Record Streak Is About To End
11:05AM  Seattle Genetics: A Performance Overview
10:14AM  XBI Mid-Caps Outperform IBB Mid-Caps
07:30AM  Global Mkts on Sale (Again) - Try the Vellutata di Verdura
Sep-25-15 05:37PM  IBB biotech fund posts largest weekly drop in 7 years at MarketWatch -6.85%
Sep-24-15 01:33PM  Biotech stocks on track for biggest weekly decline in 4 years at MarketWatch
12:07PM  Kite Led Top Ten Stocks by Weight in XBIs Biotechnology Subgroup
12:07PM  Top Ten Stocks of XBI by Weight Outperform
10:39AM  Biotech: Two Charts That Scream Sell at
09:08AM  Advaxis Led the Bottom Ten Biotechnology Stocks by Market Cap
09:07AM  Amicus Drives Small-Cap Stocks
07:52AM  Dont dump biotechnology stocks yet, says chart guru Thomas Dorsey at MarketWatch
Sep-23-15 07:13PM  Biotech ETFs Lose Steam, Extend Week's Losses at Investor's Business Daily
02:53PM  Outrage over high drug costs unlikely to bring change any time soon at MarketWatch
01:52PM  Small-Cap Biotech ETF Rallies Amid Broad Losses at Investor's Business Daily
12:08PM  Seattle Genetics Leads XBI Mid-Cap Stocks
10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
09:08AM  XBIs Biotechnology Stocks Rose Week of September 11
07:13AM  Kite Pharma and Juno Therapeutics Led Biotechnology Sector
Sep-22-15 01:55PM  Stocks Extend Sharp Losses on Oil Rout, Fed Hangover at TheStreet
12:59PM  Stocks Extend Losses on Oil Rout, Fed Hangover at TheStreet
12:36PM  Tuesday links: a bull market built on sand
11:13AM  Stocks Extend Losses on Oil Rout at TheStreet
11:06AM  IBB Mid-Cap Outperforms XBI Mid-Cap
10:17AM  Stocks Tank as Crude Oil Plummets at TheStreet
10:07AM  XBI Moving Averages Are on the Rise
09:30AM  The Zacks Analyst Blog Highlights: Twitter, iShares Nasdaq Biotechnology, First Trust NYSE Arca Biotech ETF, PowerShares Dynamic Pharmaceuticals ETF and SPDR S&P Biotech ETF
08:58AM  Stock Futures Tank as China Fears Resurface at TheStreet
08:31AM  What Hillary Clinton and Daraprim Just Did To Biotech Stocks Everywhere
07:31AM  Clinton Drug Plan Cuts Market Exclusivity, Sets Mandatory R&D Spending at TheStreet
06:50AM  [video]Sept. 22 Premarket Briefing: 10 Things You Should Know at TheStreet
Sep-21-15 08:54PM  XBI Rise 6.58% for Week Ended September 11 -5.39%
07:32PM  Thank you Mrs. Clinton for the biotech buying opportunity
06:28PM  Brutal session for biotech, health-care stocks in 3 charts at MarketWatch
03:06PM  US Equities Continue to See Outflows on Slowing Growth
02:24PM  Pill prices & politics
02:06PM  Theravance and Alder Help IBB Small-Caps
01:31PM  Stocks Turn Mixed as Rally Flames Out at TheStreet
01:20PM  The Political Tweet That Thrashed the Biotech Sector at 24/7 Wall St.
12:50PM  Biotech Drug Stocks Tank After Clinton Tweet on Price Controls at TheStreet
Sep-18-15 11:38AM  ETF Winners & Losers Post Dovish Fed Meet
Sep-17-15 07:47PM  Top Ten of XBI Outperform by Market Cap
07:47PM  Performance of XBI and IBB with Respective Benchmark Indexes
12:07PM  Small Caps of IBB Underperform from August 2531
12:07PM  Alnylam and ISIS Lead Mid-Cap Stocks
11:58AM  Even Biotech Bulls Should Be Watching This Level
Sep-16-15 03:40PM  Top Ten XBI Stocks by Market Cap Outperform August 2531
03:39PM  XLV and XBI Outperform Benchmark Indexes from August 2531
03:25PM  1 Smart Way to Play the Biotech Bounce at Motley Fool
11:42AM  The Comprehensive Guide to Biotech ETFs
Sep-15-15 05:15PM  Where's biotech's bubble?
Sep-10-15 11:06PM  Comparing IBBs and XBIs Small-Cap Stocks
Sep-08-15 07:06PM  Opko Health Reports Weak 2Q15 Results
06:49PM  What ETF Investors Can Do When Market Is Volatile at Investor's Business Daily
12:59PM  SPDR S&P Biotech ETF: A Closer Look at Motley Fool
12:08PM  Taking advantage of volatility
Sep-04-15 01:39PM  State Street Splits Coming For Retail, Biotech ETFs at
11:35AM  Incyte Helps XBI to Outperform IBBs Top 10
11:34AM  Benchmark Indexes Continue to Outperform IBB and XBI
Sep-02-15 01:03PM  XBI Pharmaceutical Valuation Rises on Strong Small-Cap Performance
01:02PM  Acadia, Neurocrine, Dyax, and Opko Trade Below 50-Day Moving Average
01:01PM  ICPT and XON Put Pressure on XBIs Biotechnology Sector
11:07AM  Why Did Intrexon Fall by 14.40%?
11:07AM  Analyzing Incyte: What Kind of Company Is It?
Sep-01-15 11:08AM  Incyte Was a Star Performer from August 1017, 2015
09:30AM  State Street Global Advisors Announces ETF Share Splits Business Wire
Aug-31-15 02:33PM  XBI Remains Flat as of August 17, 2015
10:06AM  How Does Novavax Compare to Its Competitors?
09:10AM  4 ETFs That Finished the Wild Week in Green
Aug-25-15 09:17AM  What Are IBB and XBIs Valuations?
Aug-24-15 12:43PM  Biotech Stocks Recover From Early-Morning Flash Crash at TheStreet -5.33%
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.